Biotechnology
NGNE
12.56
price up icon4.33%   0.54
 

Neurogene Inc (NGNE)
full-star
loading
Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Neurogene Inc Azioni (NGNE) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi
Revenues
100.00%
-
 -2.968
Operating Expenses
40.97%
18.78
 31.82
Interest Income/Expense
0.003
 -
Operating Income/Loss
40.97%
-18.78
 -31.82
Income/Loss From Continuing Operations Before Tax
56.93%
-16.92
 -39.28
Income/Loss From Continuing Operations After Tax
9.15%
-16.92
 -15.50
Net Income/Loss
9.15%
-16.92
 -15.50
Preferred Stock Dividends And Other Adjustments
-
 -
Attributable To Noncontrolling Interest
-
 -
Basic Average Shares
16.90
 -
Diluted Average Shares
16.90
 -
Basic Earnings Per Share
-1.00
 -
Diluted Earnings Per Share
-1.00
 -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
 -

Simile a NGNE

biotechnology GMAB
$19.80
price down icon 1.75%
biotechnology INSM
$70.30
price up icon 2.22%
biotechnology RPRX
$32.51
price up icon 0.87%
biotechnology SMMT
$26.24
price up icon 1.84%
biotechnology BNTX
$102.53
price down icon 0.01%
biotechnology ONC
$248.35
price up icon 8.46%
Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters
Capitalizzazione:     |  Volume (24 ore):